VERWENDUNG VON IL-11 ZUR VERSTÄRKUNG DER ZELLVERMITTELTEN IMMUNITÄT ZUR BEHANDLUNG VERSCHIEDENER VIRALER UND PARASITÄRER INFEKTIONEN UND KREBS

VERWENDUNG VON IL-11 ZUR VERSTÄRKUNG DER ZELLVERMITTELTEN IMMUNITÄT ZUR BEHANDLUNG VERSCHIEDENER VIRALER UND PARASITÄRER INFEKTIONEN UND KREBS

Provided by the present invention are methods of treating a variety of diseases where enhancement of cytotoxic T cell activity has shown to be beneficial including acute viral disorders such as influenza, chronic viral disorders such as Epstein-Barr Virus (EBV), human immunodeficiency virus (HIV), h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DORNER, ANDREW, J, BLISS, JUDITH, L, O'TOOLE, MARGOT, TREPICCHIO, WILLIAM, L
Format: Patent
Sprache:ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DORNER, ANDREW, J
BLISS, JUDITH, L
O'TOOLE, MARGOT
TREPICCHIO, WILLIAM, L
description Provided by the present invention are methods of treating a variety of diseases where enhancement of cytotoxic T cell activity has shown to be beneficial including acute viral disorders such as influenza, chronic viral disorders such as Epstein-Barr Virus (EBV), human immunodeficiency virus (HIV), herpes, hepatitis, and varicella zoster, parasitic infections such as malaria and tuberculosis, and cancer. In addition, provided by the present invention are methods of ex vivo enhancement of T cell activity from cells derived from patients with the above disorders followed by subsequent reintroduction of the modified cells into the patients.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ATE262919TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ATE262919TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ATE262919TT13</originalsourceid><addsrcrecordid>eNqNjEEOgjAQRdm4MOod6gFYgImJy0IHaSiDKVNM2BBi6sooCR7BC3gmL-ZAPICrn_z_3l8G7wbsGVA5PIqmQqFNGEWidVbwUNPnZYtpUmBFC8ZwWWoiMATMlqVDzQzNQgK5RGXmJ3bTXIMCZLHRVhpOh0qcpJX15FguNGZQkK6Qz6axsJDU62Bx7W-j3_xyFWwzoDQP_fDo_Dj0F3_3z04SxPv4EB2Iot0_zBeSmUR-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>VERWENDUNG VON IL-11 ZUR VERSTÄRKUNG DER ZELLVERMITTELTEN IMMUNITÄT ZUR BEHANDLUNG VERSCHIEDENER VIRALER UND PARASITÄRER INFEKTIONEN UND KREBS</title><source>esp@cenet</source><creator>DORNER, ANDREW, J ; BLISS, JUDITH, L ; O'TOOLE, MARGOT ; TREPICCHIO, WILLIAM, L</creator><creatorcontrib>DORNER, ANDREW, J ; BLISS, JUDITH, L ; O'TOOLE, MARGOT ; TREPICCHIO, WILLIAM, L</creatorcontrib><description>Provided by the present invention are methods of treating a variety of diseases where enhancement of cytotoxic T cell activity has shown to be beneficial including acute viral disorders such as influenza, chronic viral disorders such as Epstein-Barr Virus (EBV), human immunodeficiency virus (HIV), herpes, hepatitis, and varicella zoster, parasitic infections such as malaria and tuberculosis, and cancer. In addition, provided by the present invention are methods of ex vivo enhancement of T cell activity from cells derived from patients with the above disorders followed by subsequent reintroduction of the modified cells into the patients.</description><edition>7</edition><language>ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040415&amp;DB=EPODOC&amp;CC=AT&amp;NR=E262919T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040415&amp;DB=EPODOC&amp;CC=AT&amp;NR=E262919T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DORNER, ANDREW, J</creatorcontrib><creatorcontrib>BLISS, JUDITH, L</creatorcontrib><creatorcontrib>O'TOOLE, MARGOT</creatorcontrib><creatorcontrib>TREPICCHIO, WILLIAM, L</creatorcontrib><title>VERWENDUNG VON IL-11 ZUR VERSTÄRKUNG DER ZELLVERMITTELTEN IMMUNITÄT ZUR BEHANDLUNG VERSCHIEDENER VIRALER UND PARASITÄRER INFEKTIONEN UND KREBS</title><description>Provided by the present invention are methods of treating a variety of diseases where enhancement of cytotoxic T cell activity has shown to be beneficial including acute viral disorders such as influenza, chronic viral disorders such as Epstein-Barr Virus (EBV), human immunodeficiency virus (HIV), herpes, hepatitis, and varicella zoster, parasitic infections such as malaria and tuberculosis, and cancer. In addition, provided by the present invention are methods of ex vivo enhancement of T cell activity from cells derived from patients with the above disorders followed by subsequent reintroduction of the modified cells into the patients.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjEEOgjAQRdm4MOod6gFYgImJy0IHaSiDKVNM2BBi6sooCR7BC3gmL-ZAPICrn_z_3l8G7wbsGVA5PIqmQqFNGEWidVbwUNPnZYtpUmBFC8ZwWWoiMATMlqVDzQzNQgK5RGXmJ3bTXIMCZLHRVhpOh0qcpJX15FguNGZQkK6Qz6axsJDU62Bx7W-j3_xyFWwzoDQP_fDo_Dj0F3_3z04SxPv4EB2Iot0_zBeSmUR-</recordid><startdate>20040415</startdate><enddate>20040415</enddate><creator>DORNER, ANDREW, J</creator><creator>BLISS, JUDITH, L</creator><creator>O'TOOLE, MARGOT</creator><creator>TREPICCHIO, WILLIAM, L</creator><scope>EVB</scope></search><sort><creationdate>20040415</creationdate><title>VERWENDUNG VON IL-11 ZUR VERSTÄRKUNG DER ZELLVERMITTELTEN IMMUNITÄT ZUR BEHANDLUNG VERSCHIEDENER VIRALER UND PARASITÄRER INFEKTIONEN UND KREBS</title><author>DORNER, ANDREW, J ; BLISS, JUDITH, L ; O'TOOLE, MARGOT ; TREPICCHIO, WILLIAM, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ATE262919TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2004</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DORNER, ANDREW, J</creatorcontrib><creatorcontrib>BLISS, JUDITH, L</creatorcontrib><creatorcontrib>O'TOOLE, MARGOT</creatorcontrib><creatorcontrib>TREPICCHIO, WILLIAM, L</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DORNER, ANDREW, J</au><au>BLISS, JUDITH, L</au><au>O'TOOLE, MARGOT</au><au>TREPICCHIO, WILLIAM, L</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>VERWENDUNG VON IL-11 ZUR VERSTÄRKUNG DER ZELLVERMITTELTEN IMMUNITÄT ZUR BEHANDLUNG VERSCHIEDENER VIRALER UND PARASITÄRER INFEKTIONEN UND KREBS</title><date>2004-04-15</date><risdate>2004</risdate><abstract>Provided by the present invention are methods of treating a variety of diseases where enhancement of cytotoxic T cell activity has shown to be beneficial including acute viral disorders such as influenza, chronic viral disorders such as Epstein-Barr Virus (EBV), human immunodeficiency virus (HIV), herpes, hepatitis, and varicella zoster, parasitic infections such as malaria and tuberculosis, and cancer. In addition, provided by the present invention are methods of ex vivo enhancement of T cell activity from cells derived from patients with the above disorders followed by subsequent reintroduction of the modified cells into the patients.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language ger
recordid cdi_epo_espacenet_ATE262919TT1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title VERWENDUNG VON IL-11 ZUR VERSTÄRKUNG DER ZELLVERMITTELTEN IMMUNITÄT ZUR BEHANDLUNG VERSCHIEDENER VIRALER UND PARASITÄRER INFEKTIONEN UND KREBS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T09%3A01%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DORNER,%20ANDREW,%20J&rft.date=2004-04-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EATE262919TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true